Artelo Biosciences Analyst Ratings
Artelo Biosciences: Strong Buy Rating on Clinical Advancement and Solid Financials
Artelo Biosciences Analyst Ratings
HC Wainwright & Co. Maintains Buy on Artelo Biosciences, Maintains $5 Price Target
Buy Rating on Artelo Biosciences: Strong Pipeline and Market Potential
Promising Developments in Artelo Biosciences' Cancer Therapies Drive Buy Rating Recommendation
HC Wainwright & Co. Reiterates Buy on Artelo Biosciences, Maintains $5 Price Target
Artelo Biosciences Analyst Ratings
Artelo Biosciences: A Potential Leader in CACS Treatment – A Comprehensive Analysis of the Buy Rating
Analysts Offer Insights on Healthcare Companies: Ardelyx (ARDX), Community Health (CYH) and Artelo Biosciences (ARTL)
Artelo Biosciences (ARTL) Receives a Buy From Maxim Group
Analysts Offer Insights on Healthcare Companies: Larimar Therapeutics (LRMR), Artelo Biosciences (ARTL) and Unity Biotechnology (UBX)
Artelo Biosciences (ARTL) Receives a Buy From Ladenburg Thalmann & Co.
Analysts Offer Insights on Healthcare Companies: Artelo Biosciences (ARTL), Iterum Therapeutics (ITRM) and TScan Therapeutics (TCRX)
Ladenburg Thalmann & Co. Remains a Buy on Artelo Biosciences (ARTL)
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Tenet Healthcare (THC) and Artelo Biosciences (ARTL)
Artelo Biosciences (ARTL) Gets a Buy From Maxim Group
Ladenburg Thalmann Reiterates Buy on Artelo Biosciences, Maintains $60 Price Target
Artelo Biosciences (ARTL) Gets a Buy From Ladenburg Thalmann & Co.
Analysts Conflicted on These Healthcare Names: Roche Holding AG (OtherRHHVF), Artelo Biosciences (ARTL) and Siemens Healthineers AG (OtherSEMHF)
No Data